Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Altimmune Appoints Life Sciences Industry Veteran Greg Weaver as Chief Financial Officer
-
CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India
-
MiNK Therapeutics to Provide Corporate Update and Third Quarter 2024 Financial Report
-
argenx and Zai Lab Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy in China
-
Lucinity Secures Multi-Year Deal Through Microsoft’s Azure Marketplace, Expands Global Reach Across Europe and North America
-
Form 8.3 - Learning Technologies Group plc - Octopus Investments
-
Pitch n' Slay: Bitget and Morph Join Forces to Spotlight Females with $100K Seed Funding, Travel Support, Grants, and BWB Airdrop
-
Pitch n' Slay: Bitget and Morph Join Forces to Spotlight Females with $100K Seed Funding, Travel Support, Grants, and BWB Airdrop
-
RTX appoints Henrik Mørck Mogensen as new CEO
-
Avante Partners with Scylla to offer Human-in-the-Loop Remote Video Services
-
SpringWorks Therapeutics Announces Mirdametinib Data to be Presented at the 2024 Society for Neuro-Oncology (SNO) Annual Meeting
-
EvolveImmune Therapeutics Presents New Preclinical and Translational Data Highlighting Pipeline Progress for EVOLVE T Cell Engager Platform at 39th Annual Meeting of the Society for Immunotherapy of C
-
Xanadu Mines Completes $5.5 Million Placement
-
Sable Receives Additional Surface Results and Starts VTEM Survey at its Copper Queen Project in British Columbia
-
Unicycive Therapeutics Announces U.S. FDA Acceptance of the New Drug Application (NDA) for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease o
-
Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO Meeting
-
Medicenna Announces Positive Single-Agent Activity of MDNA11 from Dose Expansion Cohort and Encouraging Safety Profile in Combination with KEYTRUDA® (pembrolizumab) at the 39th Annual Meeting of SITC
-
MY’s Fresh Homemade Smoothies and Spices Celebrates Its First Anniversary with Expanded Product Lines and Enhanced Services
-
WAVE Consortium Holds Inaugural Working Group Meeting to Advance SATCOM Virtualization and Interoperability
-
Beyond Cancer Presents Promising Preclinical Data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
-
First Watch to Acquire 16 Franchise Restaurants in North and South Carolina
-
Can-Fite Achieves Milestone with First Patient Dosing in Pancreatic Cancer Phase IIa Clinical Trial
-
Agora, Inc. to Report Third Quarter 2024 Financial Results on November 25, 2024
-
RYVYL Signs MOU with Investor to Retire 8% Senior Convertible Note and Series B Convertible Preferred Stock
-
Pyxis Oncology to Host In-Person (NYC) and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201
-
Tecnoglass to Attend the Baird 2024 Global Industrial Conference
-
Qlik’s Accelerating Growth Attracts Significant Investment from Thoma Bravo and ADIA
-
NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel
-
Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board
-
ARS Pharmaceuticals Announces Exclusive Agreement with Global Allergy Leader ALK to Commercialize neffy® in Europe, Canada and Other Geographies Outside the United States
-
Mural Oncology to Participate in Two Upcoming Investor Conferences
-
Avalo Therapeutics to Present at Upcoming Investor Conferences
-
Dataprana Breaks Ground on New 30 MW Data Center Site in La Marque, Texas
-
SimiTree Promotes Melynda Capps Lee to Vice President of Operations and Growth Consulting
-
Medigene Presents Latest Data on UniTope & TraCR Technology at PEGS and SITC 2024
-
Medigene Presents Latest Data on UniTope & TraCR Technology at PEGS and SITC 2024
-
WorldInvest.org Launches Game-Changing Financial Features: Transparent Low Fees, Low Latency, and Maximized Investment Returns
-
Inspire Medical Systems, Inc. Announces $75 million Accelerated Share Repurchase Program
-
Launch of New Multi-Asset Wallet Function Enhances User Asset Management Experience at UVKXE
-
UVKXE Launches Real-Time Market Monitoring System to Help Users Seize Market Opportunities
-
OnePiece Labs Partners with AEON and TON Foundation on GameOn TON Global Gaming Hackathon
-
Probe Gold Commences Infill Drill Program at Novador Project, Quebec
-
SpringWorks Therapeutics Announces Publication of the Pivotal Phase 2b ReNeu Trial Evaluating Mirdametinib in Adults and Children with NF1-PN in the Journal of Clinical Oncology
-
Hyperscale Data Announces Date and Ratio of Reverse Stock Split
-
Brown & Brown, Inc. announces Paul Gallagher as controller
-
Brown & Brown, Inc. announces Paul Gallagher as controller
-
Scandinavian Tobacco Group A/S: Transactions in connection with share buy-back programme
-
Man Group PLC : Form 8.3 - Spirent Communications plc
-
Man Group PLC : Form 8.3 - TI Fluid Systems plc
-
Park Hotels & Resorts Inc. Reinstates 2024 Earnings Guidance; Operators and Union Finalize Long-Term Labor Agreements in Hawaii, Seattle and Boston Ending Nearly Six-Weeks of Strike Activity at Fo
